YD Bio Ltd (YDES) Key Metrics
YDES valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $419.3M
- Enterprise value
- $226.2M
- P/E (TTM)
- —
- Forward P/E
- —
- PEG ratio
- —
- Price / sales
- 338.4
- Price / book
- 51.1
- EV / EBITDA
- —
- Dividend yield
- —
- Beta
- −0.16
YDES key metrics, 2020–2025
Fiscal year ended December 31, 2025 · U.S. dollarsYDES returns How much profit the business earns on the capital it uses.
Return on assets−41.2 pts
−80.5%
2025 · hover or tap a bar for each year
20202025
Asset turnover−59.3%
0.06
2025 · hover or tap a bar for each year
20202025
YDES per-share figures Results divided by the shares outstanding at year-end.
Revenue per share
$0.01
2025 · hover or tap a bar for each year
20202025
Earnings per share
−$0.12
2025 · hover or tap a bar for each year
20202025
Free cash flow per share
−$0.12
2025 · hover or tap a bar for each year
20202025
Book value per share
−$0.04
2025 · hover or tap a bar for each year
20202025
Shares outstanding
66.7M
2025 · hover or tap a bar for each year
20202025
YDES financial health Debt, liquidity and how easily interest is covered.
Net debt−$2.9M
−$6.0M
2025 · hover or tap a bar for each year
20202025
Current ratio−55.4%
5.88
2025 · hover or tap a bar for each year
20202025
Debt / assets−85.1%
0.00
2025 · hover or tap a bar for each year
20202025
YDES efficiency & capital use Working capital cycle and where the cash goes.
Days sales outstanding+169 days
298 days
2025 · hover or tap a bar for each year
20202025
Days of inventory+493 days
547 days
2025 · hover or tap a bar for each year
20202025
Days payables outstanding+103 days
126 days
2025 · hover or tap a bar for each year
20202025
Cash conversion cycle+559 days
720 days
2025 · hover or tap a bar for each year
20202025
Capex / revenue−329.1 pts
241.3%
2025 · hover or tap a bar for each year
20202025
YDES returns on capital
ROEROICROA
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
YDES debt vs cash
Total debtCash & short-term investments
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
YDES cash returned to shareholders
DividendsBuybacksFree cash flow
YDES price vs earnings per share
Share price at year-endEPS (right axis)
YDES key metrics
2020–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| Market capitalization | $813.3M | — | — | — | — | — |
| Enterprise value | $807.3M | — | — | — | — | — |
| Earnings yield | −1.0% | — | — | — | — | — |
| Free cash flow yield | −1.0% | — | — | — | — | — |
| Share price at fiscal year-end | $12.19 | — | — | — | — | — |
| Per share | ||||||
| Revenue per share | $0.01 | — | $0.00 | — | $0.00 | $0.00 |
| Earnings per share | −$0.12 | — | $0.00 | — | $0.59 | −$0.17 |
| Operating cash flow per share | −$0.10 | — | −$0.00 | — | −$0.05 | −$0.02 |
| Free cash flow per share | −$0.12 | — | −$0.00 | — | −$0.05 | −$0.02 |
| Cash per share | $0.09 | — | $0.00 | — | $0.00 | $0.05 |
| Book value per share | −$0.04 | — | $0.00 | — | $7.45 | $6.82 |
| Tangible book value per share | −$0.08 | — | $0.00 | — | $7.45 | $6.82 |
| Capex per share | $0.02 | — | $0.00 | — | $0.00 | $0.00 |
| Debt per share | $0.00 | — | $0.00 | — | — | — |
| Shares outstanding | 66.7M | — | 70.1M | — | 14.6M | 14.6M |
| Change in shares outstanding | — | — | — | — | +0.0% | — |
| Returns & profitability | ||||||
| Return on equity (ROE) | — | −42.7% | 0.2% | 6.3% | 8.3% | −2.5% |
| Return on invested capital (ROIC) | — | −66.7% | — | −3.9% | −1.3% | −0.3% |
| Return on assets (ROA) | −80.5% | −39.3% | 0.1% | 5.6% | 7.4% | −2.2% |
| Return on tangible assets | −74.4% | −33.7% | 4.2% | 21.1% | 7.4% | −2.2% |
| Free cash flow margin | — | −930.3% | −16.0% | — | — | — |
| Income quality (OCF / net income) | — | — | −4.10 | −0.80 | −0.08 | — |
| Financial health | ||||||
| Total debt | $6,764 | $22,555 | $47,576 | — | — | — |
| Cash & short-term investments | $6.0M | $3.1M | $87,098 | $14,129 | $5,403 | $693,818 |
| Net debt | −$6.0M | −$3.1M | −$39,522 | −$14,129 | −$5,403 | −$693,818 |
| Debt / equity | — | 0.00 | 2.07 | — | — | — |
| Debt / assets | 0.00 | 0.00 | 0.15 | — | — | — |
| Net debt / EBITDA | — | — | −1.78 | −0.00 | −0.00 | — |
| Current ratio | 5.88 | 13.18 | 0.91 | 0.04 | 0.06 | 2.75 |
| Quick ratio | 4.74 | 13.04 | 0.68 | 0.04 | 0.06 | 2.75 |
| Interest coverage | — | — | -4.6 | — | — | — |
| Working capital | $8.0M | $3.2M | −$26,494 | −$5.3M | −$1.9M | $528,548 |
| Invested capital | −$8.9M | $3.5M | −$16,528 | $11.2M | $109.0M | $99.1M |
| Tangible asset value | −$5.5M | $3.9M | $22,994 | $11.2M | $109.0M | $99.8M |
| Net current asset value | −$7.0M | $3.2M | −$26,494 | −$6.5M | −$9.0M | −$17.0M |
| Graham number | — | — | $0.00 | — | $9.98 | — |
| Graham net-net per share | −$0.14 | — | −$0.00 | — | −$0.62 | −$1.17 |
| Capital allocation | ||||||
| Share buybacks (net) | — | — | — | $101.5M | — | — |
| Capex / revenue | 241.3% | 570.4% | 0.1% | — | — | — |
| Capex / depreciation | 6.87 | 27.79 | 0.12 | — | — | — |
| R&D / revenue | 268.4% | 96.3% | — | — | — | — |
| SG&A / revenue | 639.6% | 220.7% | 45.9% | — | — | — |
| Efficiency | ||||||
| Days sales outstanding | 298.2 | 129.2 | 60.7 | — | — | — |
| Days of inventory on hand | 547.5 | 54.9 | 128.8 | — | — | — |
| Days payables outstanding | 125.7 | 23.0 | 33.4 | — | — | — |
| Cash conversion cycle (days) | 720.0 | 161.1 | 156.2 | — | — | — |
| Receivables turnover | 1.22 | 2.83 | 6.01 | 0.00 | — | — |
| Payables turnover | 2.90 | 15.88 | 10.94 | — | — | — |
| Inventory turnover | 0.67 | 6.65 | 2.83 | — | — | — |
| Asset turnover | 0.06 | 0.14 | 0.04 | 0.00 | 0.00 | 0.00 |
| Average receivables | $487,530 | $180,615 | $58,254 | $18,073 | — | — |
| Average payables | $220,016 | $22,360 | $17,976 | — | — | — |
| Average inventory | $958,438 | $53,370 | $69,404 | — | — | — |
| Intangibles / total assets | 18.9% | 39.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Computed from YDES's annual financial statements (latest annual report filed December 31, 2025) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
YDES valuation and financial ratios
It ended the year with $0.0 million of debt and $6.0 million in cash and short-term investments, a net cash position of $6.0 million. The share count rose 356.2% from 14.6M to 66.7M over 5 years.
See the YDES income statement, the YDES chart for price history, or the YDES stock overview for the latest quote and news.
YDES key metrics FAQ
How much debt does YD Bio have?
YD Bio had total debt of $0.0 million at the end of fiscal 2025 and more cash than debt.
What is YD Bio's free cash flow yield?
YD Bio generated -$8.0 million of free cash flow in fiscal 2025, a free cash flow yield of −1.0% on its market value at year-end ($813.3 million).
What is YD Bio's current ratio?
YD Bio's current ratio was 5.88 at the end of fiscal 2025: current assets were 5.88 times current liabilities.